Michelle Poon

565 total citations
17 papers, 325 citations indexed

About

Michelle Poon is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Michelle Poon has authored 17 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 7 papers in Immunology. Recurrent topics in Michelle Poon's work include CAR-T cell therapy research (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immune Cell Function and Interaction (5 papers). Michelle Poon is often cited by papers focused on CAR-T cell therapy research (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immune Cell Function and Interaction (5 papers). Michelle Poon collaborates with scholars based in Singapore, United States and United Kingdom. Michelle Poon's co-authors include Andrew Grigg, Azra H. Ligon, Anne Sumbul, Nishitha Reddy, Jonathon B. Cohen, Selda Samakoglu, Stephen M. Ansell, Margaret A. Shipp, Sarit Assouline and Philippe Armand and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Michelle Poon

16 papers receiving 321 citations

Peers

Michelle Poon
Yngvild Nuvin Blaker Norway
Marie-Elisabeth Goebeler Germany
Joshua W.D. Tobin Australia
Cyrus Khan United States
Michael Fennessy United Kingdom
Huang Huang Canada
Yajuan Qin United States
Keith Fay Australia
J. Kaitlin Morrison United States
Carlota Calvo Spain
Yngvild Nuvin Blaker Norway
Michelle Poon
Citations per year, relative to Michelle Poon Michelle Poon (= 1×) peers Yngvild Nuvin Blaker

Countries citing papers authored by Michelle Poon

Since Specialization
Citations

This map shows the geographic impact of Michelle Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Poon more than expected).

Fields of papers citing papers by Michelle Poon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Poon. The network helps show where Michelle Poon may publish in the future.

Co-authorship network of co-authors of Michelle Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Poon. A scholar is included among the top collaborators of Michelle Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Poon. Michelle Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
Blasiak, Agata, Xavier Tadeo, Kirthika Senthil Kumar, et al.. (2024). Personalized dose selection for the first Waldenström macroglobulinemia patient on the PRECISE CURATE.AI trial. npj Digital Medicine. 7(1). 223–223. 6 indexed citations
4.
Sureda, Anna, Pieternella J. Lugtenburg, Marie José Kersten, et al.. (2023). Cellular therapy in lymphoma. Hematological Oncology. 42(6). e3200–e3200. 3 indexed citations
5.
6.
Lim, Chwee Ming, Anthony K. F. Liou, Michelle Poon, et al.. (2022). Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma. Cancer Immunology Immunotherapy. 71(9). 2277–2286. 22 indexed citations
7.
Lim, Mei Chin, et al.. (2021). Low-dose ‘boom-boom’ radiotherapy for ocular lymphoma arising from IgG4-related ophthalmic disease: Case report and literature review. European Journal of Ophthalmology. 32(6). NP78–NP84. 3 indexed citations
8.
Walsh, Robert J., Yating Li, Bhushan Dharmadhikari, et al.. (2020). Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma (NPC).. Journal of Clinical Oncology. 38(15_suppl). 6535–6535. 2 indexed citations
9.
10.
Lim, Chwee Ming, Anthony K. F. Liou, Michelle Poon, et al.. (2020). Abstract B03: A phase I study of cetuximab followed by activated and expanded NK cells for refractory nasopharyngeal cancer. Clinical Cancer Research. 26(12_Supplement_2). B03–B03. 2 indexed citations
11.
Fan, Shuangyi, Michał Marek Hoppe, Sanjay De Mel, et al.. (2019). Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma. Journal of Visualized Experiments. 3 indexed citations
12.
Zeng, Qun, et al.. (2019). Plasma Factors for the Differentiation of Hodgkin’s Lymphoma and Diffused Large B Cell Lymphoma and for Monitoring Remission. Journal of Hematology. 8(2). 47–54. 4 indexed citations
13.
Ansell, Stephen M., Monique C. Minnema, Peter Johnson, et al.. (2019). Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study. Journal of Clinical Oncology. 37(6). 481–489. 249 indexed citations
14.
Poon, Michelle, Yeh Ching Linn, Noriko Shimasaki, et al.. (2016). A First-in-Human Study of Autologous T Lymphocytes with Antibody-Dependent Cell Cytotoxicity (ADCC) in Patients with B-Cell Non-Hodgkin Lymphoma (NHL). Blood. 128(22). 3031–3031. 4 indexed citations
15.
Lee, Soo Chin, Noriko Shimasaki, Lip Kun Tan, et al.. (2016). Phase Ib/II trial of expanded and activated autologous natural killer (NK) cells with trastuzumab (Tras) in refractory HER2+ metastatic breast cancer (MBC).. Journal of Clinical Oncology. 34(15_suppl). 3045–3045. 2 indexed citations
16.
Fancourt, Daisy & Michelle Poon. (2015). Validation of the Arts Observational Scale (ArtsObS) for the evaluation of performing arts activities in health care settings. Arts & Health. 8(2). 140–153. 12 indexed citations
17.
Tan, Lip Kun, et al.. (2014). Evaluation of Blood Group Conversion Following ABO-Incompatible Hematopoietic Stem Cell Transplantation (HCT). Blood. 124(21). 1557–1557. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yngvild Nuvin Blaker Breakdown of academic impact, for papers by Marie-Elisabeth Goebeler Breakdown of academic impact, for papers by Joshua W.D. Tobin Breakdown of academic impact, for papers by Cyrus Khan Breakdown of academic impact, for papers by Michael Fennessy Breakdown of academic impact, for papers by Huang Huang Breakdown of academic impact, for papers by Yajuan Qin Breakdown of academic impact, for papers by Keith Fay Breakdown of academic impact, for papers by J. Kaitlin Morrison Breakdown of academic impact, for papers by Carlota Calvo
Rankless by CCL
2026